- Welcome folks.

Today is a special day.

We've got your recorded questions.

We're gonna put it on most of the program.

We'll be answering the questions that

came from the audience.

But first, the stock market has soared

after stunning news in thefight against COVID-19.

Drug company, Pfizer,is ramping up production

of a vaccine reported to be 90% effective.

How soon would it beavailable to Americans?

And what could it mean for our economy

and our return to a normal life?

Our Medical Reporter, Lorie Johnson,

is joining us right now.

Lorie, this vaccine theysay is 90% effective.

I understand that's betterthan the flu vaccine.

- Actually it's much betterthan the flu vaccine.

The flu vaccine, the efficacyvaries from year to year,

but in general, it's about 60% effective.

This new COVID-19 vaccine has been shown

to be 90% effective.

The FDA said they wouldsettle for a vaccine

that was only 50% effective.

So this is really right up there

with some of our most effective vaccines.

I'm talking about some ofthese childhood vaccines,

such as for the measles.

And Pat, you'll be happy to know that

this particular vaccine,the Pfizer vaccine,

is not made using a livevirus or even a dead virus.

It's made using this messenger RNA,

which is genetic material thattriggers an immune response.

The only catch about the mRNA vaccine

is that it has to be kept frozen.

This genetic materialfalls apart if it thaws.

And so, you know, lots ofdry ice and great freezers

need to be used fromthe moment it's produced

until it's delivered,but that's not a problem.

And scientists have knownabout this all along.

So this is a Pfizer vaccine.

It looks like it's gonna be the first one

to cross the finish line.

Although there are three othersthat are in the homestretch

and we've been talking about these.

The Moderna vaccine is likelyto be approved very soon.

This also uses mRNA and italso needs to be frozen.

Then there's the AstraZeneca vaccine.

This does not need to be frozen.

It only needs to be refrigerated.

All three of thesevaccines require two doses.

So you get a shot andthen three weeks later

you get another shot.

And then the lastvaccine, that's very close

to being approved is Johnson and Johnson.

That's only one shot.

- The FDA has approvedemergency use of this

new antibody drug.

What do you know about that?

- Well, this is the onecalled bamlanivimab.

And this is the drugthat Chris Christie took.

You may remember, he wasdiagnosed with Coronavirus

and went into the hospital right away,

because he does have some risk factors.

He's over 55 and his weight is an issue.

And he was given this drugand recovered right away.

This is an antibody drug,and this is very similar

to the antibody drug thatPresident Trump received

that was so very effective.

So this particular drug made by Eli Lilly,

it's an IV infusion,and it needs to be given

in the very early stages of the disease.

So if a person comesinto the doctor's office

and they test positive for Coronavirus

and they have a lot of risk factors,

then they go straight tothe hospital and get this.

And the results have beenremarkable up until this point.

- Thank you, Lorie.

You know, the peoplein Germany were asking,

"Why did you hold this thing so long?"

And they said, "Look, wedidn't wanna play politics,

but it is a little strange.

But nevertheless, it's incredible.

This was developed under theadministration of Donald Trump

and he has a Four StarGeneral in place to get these

vaccines out to the generalpublic in record time,

all across the country.

It's all set, and assoon as we get clearance

and we can begin delivering them,

they'll put out as manyas 50 million doses.

I think they're gonna startwith about five million,

but it's an incrediblebreakthrough in this dreadful

dreadful pandemic.

We'll CBN News FinancialEditor, Drew Parkhill,

has joined us now andDrew, apparently the market

just loves the news of this vaccine.

What's your take on it?

- You know, the fascinating thing Pat was,

this impact on the marketwas very, very split up.

Let me show you what I mean.

Lorie talked about the Pfizer, Moderna.

Well their stocks yesterday,we have a couple graphics here.

Their stocks yesterdaywere way up, obviously.

Pfizer is up nearly 8%, Modernawas up a little over 7%,

'cause they're working on a vaccine too.

But, the spillovereffect into other stocks,

travel and leisure stocks.

We have a graphic about that as well.

Some of these stocks went way up.

American Airlines, Delta, way up.

Royal Caribbean up 29% in a day.

Disney up.

The idea is here that eventually,

whether it's right away or later,

eventually people willstart traveling again.

They'll come out of their houses.

Their businesses will be backup, the ones that have been

closed down or at leastslowed down temporarily.

So these were the stocksthat did really well.

By contrast, let's look at some of the,

what are called the stay at home stocks.

These stocks have been doing really well.

I mean, people werebuying things from Amazon.

They were watching Netflix.

They'd be using Facebook.

They, of course, useMicrosoft Windows and Apple

for iPhones and so forth.

Those stocks had been doing great.

Yesterday, they sold off.

Why?

Because the money went into other stocks

and people said, "Okay,their day in the sun

is kind of over."

So it had a bit of a mixed impact.

But the basic idea here is, Pat,

you've gotta have a vaccine or vaccines

to reopen the economy again.

That's what Biden, who,you know, if he wins,

that's what he's talking about.

Trump would be operating the same way.

You're right, this was developed under

the Trump administration.

Whoever is declared the ultimate winner

and is certified, they're going to inherit

what should be a good situation.

Now it may take a fewyears or several months

to work itself out, butit looks pretty promising

at this point.

- One last question, Drew,

I know you're a crystalball prognosticator.

You're not surprisedat the top of the Dow,

but you think the Dow might goup to 30, 40, 50, 60, 70,000.

- Well, you know, yesterday,the Dow got very close

to 30,000, then it turned back.

That may be resistance for a while.

And like I said, you know,I've expected a bear market.

We had one basically inthat really sharp sell-off

from late February to late March,

where the Dow went from 29,000

and changed to just over 18,000.

Maybe that got the bearmarket out of its system,

or maybe we're gonna havea few sideways years yet.

That's just a matter of timing.

Longer term, Pat.

Longer term.

We're just under 30,000 now.

Well, okay, in March of2009 we were at 6,500.

So in 11 years, 11 and a half years,

we've gone from 6,500 to almost 30,000.

So that's a gain of like 330%.

But to go from 30,000 to 100,000,

the market would only have to go up 230%.

You see what I'm saying?

No doubt in my mind, economicpolicy will play a part

out of Washington.

But no doubt in my mind,over let's say 15 years,

the Dow will go over 100,000.

I'd say within a little over 20 years,

it'll go over 150,000.

- Wow.

Our Financial Reporter, keep that in mind.

The joke used to be in the South,

save your Confederate dollars,the South will rise again.

(laughing)

- The Dow is definitely gonna rise

and the rest of the market with it.

- It looks like Americais gonna keep on rising.

Okay.

Don't bet against the Fed, that's the key.

And the Fed has beenpumping money like crazy

and don't bet againstAmerica because this is

the greatest country onthe face of the earth.

Wendy.

- It's so much more funwhen the market's going up.

- It makes you feel so much better.

You look at your IRA orKeogh, or whatever you got

and you say, hey, this looks so nice.

Okay.